Forcyte Biotechnologies, Inc

📍 Los Angeles, United States🗓 Founded 2017👥 7 employees💰 Last funded Mar 2017
Forcyte Biotechnologies is putting the Focus On Force in disease. As mechanical force underlies important processes in all cells, it is a key functional component driving various diseases - (asthma, hypertension, preterm labor, intestinal dysmotility, many others). Forcyte is commercializing the (UCLA-developed) FLECS Technology Platform for high-throughput analysis of contractile cell force. We develop assays, build hardware, supply software, and perform services to functionally characterize cellular force in high-throughput, down to the single-cell level! Our mission is to: 1) enable the budding field of "Force Biology"​ to automate their data collection in a standardized format to allow for direct comparison between studies, and to ultimately remove the barriers to entry for all researchers 2) provide functional high-throughput data on cellular force to support drug development in pharma, including phenotypic drug discovery, functional quantification / dose-response, toxicology, off-target effects, and general confirmation that desired contractile function is ultimately achieved See our website for more info!
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Forcyte Biotechnologies, Inc?
Forcyte Biotechnologies, Inc has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Forcyte Biotechnologies, Inc last raise funding?
The most recent investment in Forcyte Biotechnologies, Inc recorded on gritt.io was in March 2017.
When was Forcyte Biotechnologies, Inc founded?
Forcyte Biotechnologies, Inc was founded in 2017.
What industry is Forcyte Biotechnologies, Inc in?
Forcyte Biotechnologies, Inc operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Forcyte Biotechnologies, Inc based?
Forcyte Biotechnologies, Inc is headquartered in Los Angeles, United States.